Avillion LLP

5:00 PM - 5:15 PM, Monday, June 3,2019 ・ Theater 4
Accelerating global drug development through successful partnering for patient benefit. Our objective is to enable our partners to continue to develop their most important drug candidates without increasing the burden on their P&L or cash reserves.
Speaker
photo
CEO
Avillion LLP